Plant genetic factors for iron homeostasis affect iron bioavailability in Caco-2 cells

2010 ◽  
Vol 43 (6) ◽  
pp. 1661-1665
Author(s):  
Felix Maurer ◽  
Nicole Daum ◽  
Ulrich F. Schaefer ◽  
Claus-Michael Lehr ◽  
Petra Bauer
Genes ◽  
2021 ◽  
Vol 12 (8) ◽  
pp. 1120
Author(s):  
Raquel Sorribes-Dauden ◽  
María Teresa Martínez-Pastor ◽  
Sergi Puig

Iron is an essential micronutrient for all eukaryotic organisms because it participates as a redox cofactor in multiple metabolic processes. Iron bioavailability is highly restricted due to the low solubility of its oxidized form, frequently leading to iron deficiency anemia. The baker’s yeast Saccharomyces cerevisiae is used as a model organism for iron homeostasis studies, but also as a food supplement and fermentative microorganism in the food industry. Yeast cells use the vacuolar Ccc1 transporter to detoxify and store excess iron in the vacuoles. Here, we modulate CCC1 expression and properties to increase iron extraction from the environment. We show that constitutive expression of full-length CCC1 is toxic, whereas deletion of its cytosolic amino-terminal (Nt) domain (NtDCCC1) rescues this phenotype. Toxicity is exacerbated in cells lacking AFT1 transcription factor. Further characterization of NtDCcc1 protein suggests that it is a partially functional protein. Western blot analyses indicate that deletion of Ccc1 Nt domain does not significantly alter GFP-Ccc1 protein stability. A functional full-length GFP-Ccc1 protein localized to particular regions of the vacuolar membrane, whereas GFP-NtDCcc1 protein was evenly distributed throughout this endogenous membrane. Interestingly, expression of NtDCCC1 increased the accumulation of endogenous iron in cells cultivated under iron-sufficient conditions, a strategy that could be used to extract iron from media that are not rich in iron.


Blood ◽  
2011 ◽  
Vol 117 (18) ◽  
pp. 4915-4923 ◽  
Author(s):  
Andrea U. Steinbicker ◽  
Chetana Sachidanandan ◽  
Ashley J. Vonner ◽  
Rushdia Z. Yusuf ◽  
Donna Y. Deng ◽  
...  

Abstract Anemia of inflammation develops in settings of chronic inflammatory, infectious, or neoplastic disease. In this highly prevalent form of anemia, inflammatory cytokines, including IL-6, stimulate hepatic expression of hepcidin, which negatively regulates iron bioavailability by inactivating ferroportin. Hepcidin is transcriptionally regulated by IL-6 and bone morphogenetic protein (BMP) signaling. We hypothesized that inhibiting BMP signaling can reduce hepcidin expression and ameliorate hypoferremia and anemia associated with inflammation. In human hepatoma cells, IL-6–induced hepcidin expression, an effect that was inhibited by treatment with a BMP type I receptor inhibitor, LDN-193189, or BMP ligand antagonists noggin and ALK3-Fc. In zebrafish, the induction of hepcidin expression by transgenic expression of IL-6 was also reduced by LDN-193189. In mice, treatment with IL-6 or turpentine increased hepcidin expression and reduced serum iron, effects that were inhibited by LDN-193189 or ALK3-Fc. Chronic turpentine treatment led to microcytic anemia, which was prevented by concurrent administration of LDN-193189 or attenuated when LDN-193189 was administered after anemia was established. Our studies support the concept that BMP and IL-6 act together to regulate iron homeostasis and suggest that inhibition of BMP signaling may be an effective strategy for the treatment of anemia of inflammation.


Author(s):  
K. Rajamanickam ◽  
M. Sameer Ali ◽  
V. Leela

Hepcidin is an important hormone regulating the systemic iron bio-availability. Blood samples were collected from thirty pregnant cattle during their last trimester of pregnancy to assess the relation of hepcidin to iron homeostasis. Serum hepcidin level was quantified using ELISA and serum iron, transferrin iron binding capacity and unsaturated iron binding capacity were estimated by colorimetric method. Correlation between hepcidin and other iron related parameters was assessed. Dependency of serum iron level on hepcidin was also determined by regression method. It was revealed that hepcidin was negatively correlated to serum iron and transferrin iron binding capacity (p less than 0.001) and also hepcidin has highest predictive value on serum iron level and transferrin iron binding capacity (p less than 0.001). It can be concluded that during pregnancy increase in hepcidin reduces the maternal serum iron and also it is a biomarker for iron bioavailability to the developing fetus.


2020 ◽  
Vol 26 (10) ◽  
pp. 1025-1035 ◽  
Author(s):  
Raffaela Rametta ◽  
Anna L. Fracanzani ◽  
Silvia Fargion ◽  
Paola Dongiovanni

: Hyperferritinemia is observed in one-third of patients with non-alcoholic fatty liver disease (NAFLD) and Metabolic Syndrome (MetS). The condition characterized by increased body iron stores associated with components of MetS has been defined as Dysmetabolic Iron Overload Syndrome (DIOS). DIOS represents the most frequent iron overload condition, since it is observed in 15% of patients with MetS and in half of those with NAFLD and its clinical presentation overlaps almost completely with that of dysmetabolic hyperferritinemia (DH). : The pathogenetic mechanisms linking insulin resistance (IR), NAFLD and DIOS to iron overload are still debated. Hepcidin seems to play a role in iron accumulation in DIOS and NAFLD patients who show elevated serum hepcidin levels. The iron challenge does not restrain iron absorption despite adequate hepcidin production, suggesting that an impaired hepcidin activity rather than a deficit of hormone production underlies DIOS pathogenesis. : Acquired and genetic factors are recognized to contribute to iron accumulation in NAFLD whereas additional studies are required to clearly demonstrate whether the same or different genetic factors lead to iron overload in DIOS. : Finally, iron depletion by phlebotomy, together with the modification of diet and life-style habits, represents the therapeutic approach to decrease metabolic alterations and liver enzymes in NAFLD and DIOS patients. : n this review, we summarized the current knowledge on the dysregulation of iron homeostasis in NAFLD and DIOS in the attempt to clarify whether they are different or more likely strictly related conditions, sharing the same pathogenic cause i.e. the MetS.


Author(s):  
Satya Prasad Dixit ◽  
Logesh Rajan ◽  
Dhanabal Palaniswamy ◽  
Suresh Kumar Mohankumar

: Iron is one of the essential elements required for human health, as it plays a vital role in a number of metabolic, growth and developmental processes, including erythropoiesis, DNA synthesis, electron transport and others. Iron deficiency is a concern in both developing and developed (industrialized) countries, and in particular young women are highly vulnerable. This review investigates dietary and genetic determinants of iron metabolism in the human body and a possible solution to combat the iron deficiency by exploring via various targets. Hence, this review mainly focuses on the assessment of dietary and genetic factors affecting the iron bioavailability and homeostasis and collates the available information from 2000 to till date from Pubmed. The dietary factors including ascorbic acid an important factor in animal protein foods (meat, fish and poultry) enhance iron absorption whereas the phytic acid, soy protein, calcium and polyphenols have been reported to inhibit iron absorption. However, the effects of these dietary factors on iron absorption do not necessarily translate into an association with iron status and iron stores (serum ferritin concentration). Moreover, the genetic factors influence the absorption of iron involving HFE, TFR2, FPN1 and HAMP in humans. Further research is needed to determine optimal dietary recommendations for both the prevention and treatment of iron deficiency.


Blood ◽  
2005 ◽  
Vol 106 (11) ◽  
pp. 3579-3579
Author(s):  
Armin Schumacher ◽  
Henry Mok ◽  
Agnieszka E. Mlodnicka ◽  
Matthias W. Hentze ◽  
Martina Muckenthaler

Abstract Recent positional cloning of the radiation-induced polycythaemia (Pcm) mutation revealed a 58-bp microdeletion in the promoter region of ferroportin 1 (Fpn1), the sole cellular iron exporter identified to date. The microdeletion causes aberrant transcription initiation and results in the absence of the iron-responsive element in the 5′ untranslated region of the vast majority of Fpn1 transcripts, thereby disrupting translational regulation of Fpn1 expression. Pcm mutant mice exhibit the gamut of iron balance disorders, ranging from iron deficiency at birth to tissue iron overload by young adulthood. Consistent with the perinatal iron deficiency, Pcm pups display a microcytic, hypochromic anemia. Strikingly, the majority of young adult Pcm heterozygous animals display a transient erythropoietin (Epo)-dependent polycythemia with peak hematocrits of up to 80%, eponymous of the mutant strain. Here we report a molecular definition of the regulatory mechanisms governing the dynamic changes in iron balance in Pcm heterozygous mice between 3 and 12 weeks of age. Therein, hepatic and/or duodenal response patterns of iron transporters, such as Trfr, cybrd1 and Slc11a2, defined the transition from early postnatal iron deficiency to iron overload by 12 weeks of age. A significant delay in developmental upregulation of hepcidin (Hamp), the pivotal hormonal regulator of iron homeostasis, correlated with high levels of Fpn1 expression in hepatic Kupffer cells during postnatal development. Conversely, upon upregulation of Hamp expression at 12 weeks of age, Fpn1 expression decreased, indicative of a Hamp-mediated homeostatic loop. Aged cohorts of Pcm mice exhibited low levels of Fpn1 expression in the context of an iron-deficiency erythropoiesis and profound iron sequestration in reticuloendothelial macrophages, duodenum and other tissues. Similar to the anemia of chronic disease, these findings are consistent with decreased iron bioavailability due to sustained downregulation of Fpn1 levels by Hamp. Therefore, iron-deficiency erythropoiesis marks both the beginning and the endpoint of the hematopoietic defects in Pcm mice. However, whereas the embryonic/perinatal anemia results from primary organismal iron deficiency, adult Pcm mice develop anemia due to decreased iron bioavailability despite organismal iron overload. The polycythemia develops at the transition phase between the two disease states, governed by unimpeded Epo signaling. We conclude that regulatory alleles, such as Pcm, with highly dynamic changes in iron balance are ideally suited to interrogate the genetic circuitry regulating iron metabolism.


Author(s):  
Daniel Valenzuela‐Heredia ◽  
Carlos Henríquez‐Castillo ◽  
Raúl Donoso ◽  
Paris Lavín ◽  
Michael T. Ringel ◽  
...  

Author(s):  
Prameela Kannan Kutty

The biological equilibrium of iron, a potent, multifunctional micronutrient is a decisive factor in the holistic health of the mother and child. Iron dysequilibrium impairs organ function, effects growth and development and predisposes to a spectrum of disease states. This article revisits the homeostasis of body iron in early life as a sequential continuum from prenatal to early post- natal life ,then reviews, compares and attempts to integrate intra and early extra uterine events related to iron metabolism. The “adaptive evolutionary” mechanisms involved in iron homeostasis in early life such as the transfer of iron from the mother to the feto-placenta unit and from the lactating mammary glands into breastmilk are revisited as both organs support life during dynamic developmental stages of growth and differentiation. The checks and balances of iron metabolism in pregnancy also endow some iron to the feto-placental unit, by actively transporting iron from the mother to the developing fetus. In early postnatal life the mechanisms involved in iron absorption are not yet fully mature, and other sources of iron such as transplacentally transferred iron and the iron stored from hemolysis of the rapidly decreasing red blood cell (RBC) mass contribute to early iron equilibrium. Additionally, although breastmilk is low in iron, the concept of active iron bioavailability in the breastfed infant provides utilizable iron. The lactating mammary glands may adopt unique features of iron metabolism adapted to the individual infant with the iron content in breastmilk largely, but not entirely, independent of maternal iron status. Early physiological iron equilibrium reflects essential homeostatic complexity, highlighting that exogenous iron, when required, must also be weighed for its benefits against its risks, as evident in the cautious homeostasis in our biological systems.


2019 ◽  
Vol 149 (6) ◽  
pp. 1004-1011 ◽  
Author(s):  
Anat Yaskolka Meir ◽  
Gal Tsaban ◽  
Hila Zelicha ◽  
Ehud Rinott ◽  
Alon Kaplan ◽  
...  

ABSTRACTBackgroundDecreased dietary meat may deplete iron stores, as plant-derived iron bioavailability is typically limited.ObjectivesWe explored the effect of a low-meat Mediterranean (green-MED) diet, supplemented with Wolffia globosa duckweed (Mankai: rich in protein and iron) as a food source for humans, on iron status. We further examined the iron bioavailability of Mankai in rats.MethodsTwo hundred and ninety-four abdominally obese/dyslipidemic [mean age = 51.1 y; body mass index (kg/m2) = 31.3; 88% men] nonanemic participants were randomly assigned to physical activity (PA), PA + MED diet, or PA + green-MED diet. Both isocaloric MED groups consumed 28 g walnuts/d and the low-meat green-MED group further consumed green tea (800 mL/d) and Mankai (100 g green shake/d). In a complementary animal experiment, after 44 d of an iron deficiency anemia–inducing diet, 50 female rats (age = 3 wk; Sprague Dawley strain) were randomly assigned into: iron-deficient diet (vehicle), or vehicle + iso-iron: ferrous gluconate (FG) 14, Mankai 50, and Mankai 80 versions (1.7 mg · kg−1 · d−1 elemental iron), or FG9.5 and Mankai 50-C version (1.15 mg · kg−1 · d−1 elemental iron). The specific primary aim for both studies was changes in iron homeostasis parameters.ResultsAfter 6 mo of intervention, iron status trajectory did not differ between the PA and PA + MED groups. Hemoglobin modestly increased in the PA + green-MED group (0.23 g/dL) compared with PA (−0.1 g/dL; P < 0.001) and PA + MED (−0.1 g/dL; P < 0.001). Serum iron and serum transferrin saturation increased in the PA + green-MED group compared with the PA group (8.21 μg/dL compared with −5.23 μg/dL and 2.39% compared with −1.15%, respectively; P < 0.05 for both comparisons), as did folic acid (P = 0.011). In rats, hemoglobin decreased from 15.7 to 9.4 mg/dL after 44 d of diet-induced anemia. After depletion treatment, the vehicle-treated group had a further decrease of 1.3 mg/dL, whereas hemoglobin concentrations in both FG and Mankai iso-iron treatments similarly rebounded (FG14: +10.8 mg/dL, Mankai 50: +6.4 mg/dL, Mankai 80: +7.3 mg/dL; FG9.5: +5.1 mg/dL, Mankai 50-C: +7.1 mg/dL; P < 0.05 for all vs. the vehicle group).ConclusionsIn humans, a green-MED low-meat diet does not impair iron homeostasis. In rats, iron derived from Mankai (a green-plant protein source) is bioavailable and efficient in reversal of anemia. This trial was registered at clinicaltrials.gov as NCT03020186.


2009 ◽  
Vol 2009 ◽  
pp. 1-6 ◽  
Author(s):  
Gérald Le Gac ◽  
Chandran Ka ◽  
Isabelle Gourlaouen ◽  
Laurence Bryckaert ◽  
Anne-Yvonne Mercier ◽  
...  

Phenotypic expression of the common p.C282Y/p.C282YHFE-related hemochromatosis genotype is heterogeneous and depends on a complex interplay of genetic and non-genetic factors. Haptoglobin has a crucial role in free hemoglobin iron recovery, and exists as three major types: Hp1-1, Hp2-1 and Hp2-2. Hp2-2 favors endocytosis of hemoglobin iron in monocytes/macrophages, resulting in partial iron retention and increased intracellular ferritin levels. This situation is generally not expected to severely affect iron homeostasis, but was found to correlate with elevated serum iron indices in healthy men. Whether the Hp2-2 genotype acts as a modifier inHFE-related hemochromatosis is unclear. In this study we investigated influence of Hp2-2 and of potential confounders on the iron indices of 351 p.C282Y homozygous patients. We conclude that there is a cause-and-effect relationship between the Hp2-2 genotype and increased iron indices in p.C282Y homozygous patients. The Hp2-2 effect is, however, limited and only apparent in males.


Sign in / Sign up

Export Citation Format

Share Document